AlphaGrep UK’s Chemed CHE Stock Holding History

AlphaGrep UK’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,387	Closed	-$524K	–	767
2026 Q1	$524K	Buy	1,387 +285	+26%	+$122K	0.15%	228
2025 Q4	$472K	Buy	+1,102	New	+$480K	0.16%	230

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AlphaGrep UK's CHE Position: Q2 2026 in Review

AlphaGrep UK sold out of Chemed (CHE) in Q2 2026, closing a stake of 1,387 shares — an estimated $524K sold.

AlphaGrep UK first reported a position in CHE in Q4 2025 and held it in 2 quarters. The position peaked at $524K in Q1 2026. 497 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

AlphaGrep UK reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 1,387 Chemed shares in Q2 2026, an estimated $524K.
AlphaGrep UK first reported a position in Chemed in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Chemed position peaked at $524K in Q1 2026.
497 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.